We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
-2.32%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
AUM
$415M
AUM Growth
+$3.41M
Cap. Flow
+$22.6M
Cap. Flow %
5.44%
Top 10 Hldgs %
36.66%
Holding
219
New
18
Increased
92
Reduced
67
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 24.7%
2 Financials 11.51%
3 Healthcare 8.79%
4 Industrials 7.59%
5 Consumer Discretionary 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGRN
201
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$40.4K 0.01%
57,000
-250,890
-81% -$207K
SMMT icon
202
Summit Therapeutics
SMMT
$11.1B
$18.7K ﹤0.01%
10,000
TELL
203
DELISTED
Tellurian Inc.
TELL
$17.4K ﹤0.01%
15,000
-8,000
-35% -$10.9K
KNTE
204
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$17.4K ﹤0.01%
+12,398
New +$29.8K
INTZ
205
DELISTED
INTRUSION INC NEW
INTZ
$10.3K ﹤0.01%
29,405
-4,000
-12% -$1.4K
BAX icon
206
Baxter International
BAX
$14.2B
-6,365
Closed -$290K
EXEL icon
207
CALL
Exelixis
EXEL
$13.4B
-50,000
Closed -$27.5K
F icon
208
CALL
Ford
F
$55.7B
-100,000
Closed -$157K
HII icon
209
Huntington Ingalls Industries
HII
$12.8B
-915
Closed -$208K
IRDM icon
210
Iridium Communications
IRDM
$5.29B
-3,625
Closed -$225K
IYF icon
211
iShares US Financials ETF
IYF
$4.61B
-5,130
Closed -$383K
LVS icon
212
Las Vegas Sands
LVS
$29.6B
-3,635
Closed -$211K
NUE icon
213
Nucor
NUE
$62.1B
-1,247
Closed -$204K
RTX icon
214
RTX Corp
RTX
$301B
-2,525
Closed -$247K
TARS icon
215
Tarsus Pharmaceuticals
TARS
$2.84B
-10,045
Closed -$182K
TSHA icon
216
Taysha Gene Therapies
TSHA
$1.89B
-25,634
Closed -$16.9K
WASH icon
217
Washington Trust Bancorp
WASH
$741M
-10,900
Closed -$292K
XYZ
218
Block Inc
XYZ
$47.5B
-4,187
Closed -$279K
SPPI
219
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-975,600
Closed -$937K

Similar funds

Sargent Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Sargent Investment Group held 219 positions worth $415M, up 0.83% from $412M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sargent Investment Group deployed $22.6M of net new capital in Q3 2023, opening 18 new positions and adding to 92 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 4 shares worth $2.13M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Blackstone, an estimated $906K trimmed.

  • Sargent Investment Group's largest Q3 2023 buy was Berkshire Hathaway Class A: 4 shares worth $2.13M.
  • Sargent Investment Group added most to State Street SPDR Bloomberg 3-12 Month T-Bill ETF in Q3 2023, an estimated $10.9M increase.
  • Sargent Investment Group's biggest Q3 2023 reduction was Blackstone, cutting an estimated $906K.
  • Sargent Investment Group fully exited Spectrum Pharmaceuticals Inc in Q3 2023, selling an estimated $937K.
  • Sargent Investment Group's ten largest holdings make up 37% of its $415M portfolio in Q3 2023.
  • Sargent Investment Group opened 18 new positions and closed 14 in Q3 2023.
  • Sargent Investment Group's portfolio value rose 0.83% quarter-over-quarter to $415M.

Based on Sargent Investment Group's 13F filing for Q3 2023, filed 13 Nov 2023.